Novavax (NVAX) Invested Capital (2024 - 2025)
Novavax's (NVAX) quarterly Invested Capital came in at $4.6 million in Q4 2025, down 92.43% year-on-year from $60.7 million in Q4 2024, and down 92.43% quarter-over-quarter from $60.7 million in Q4 2024.
Novavax (NVAX) Invested Capital (2024 - 2025) Analysis & Trends
Novavax's Invested Capital history runs 2 years deep, the most recent figure standing at $4.6 million for Q4 2025.
- On a quarterly basis, Invested Capital fell 92.43% year-over-year to $4.6 million in Q4 2025; TTM through Mar 2026 was $4.6 million, a 92.43% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, down 92.43% from the prior year.
- Invested Capital fell to $4.6 million in Q4 2025 per NVAX's latest filing, from $60.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $60.7 million in Q4 2024 and bottomed at $4.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.60 Mn |
| Dec 31, 2024 | 60.74 Mn |